Overview
Private equity (PE) buyers are no longer treating artificial intelligence (AI) as a niche diligence issue reserved for targets whose product and service offerings primarily focus on AI. Due to a proliferation of AI laws in the United States (US) and abroad, AI-related risk increasingly matters even when a company merely uses AI in selected parts of its business. PE buyers are increasingly conducting robust AI due diligence in all transactions where AI is used, irrespective of whether AI is the primary business focus of the target. This shift reflects the growing market practice of negotiating AI-specific representations and warranties for targets whose value, operations or customer offering utilize AI. In practical terms, AI diligence now sits in its own workstream at the intersection of intellectual property (IP), privacy, cybersecurity, product performance, customer contracting, governance and sector regulation, rather than inside a narrow information technology (IT) checklist.
Business and legal questions buyers now need answered early in the diligence process
Even in deals involving companies that are not “AI companies” in the pure-play sense, buyers should now ask whether the target:
- Offers AI-enabled products or services to customers
- Uses AI internally in important workflows or analyses that are then packaged for customers
- Utilizes AI models under license from a third-party
- Has AI models in development in-house
These questions matter because many businesses are dependent upon external third-party AI providers rather than developing and owning the underlying model, and that dependence can make the value of the target contingent on a third party’s continued technology, licensing posture, use of the company’s data, cost structure and commercial roadmap. PE buyers should also test whether the target has appropriately notified customers, regulators and investors about its AI capabilities (and obtained consent to use customers’ data in connection with AI tools), because inflated or unverified claims, (or a lack of consumer consent), can turn into misrepresentations, indemnification claims and diminished-value disputes after closing. In cases where the target aggressively markets the quality/efficiency of its AI tools and related products and services, AI diligence should move past slideware and require evidence on model performance, intended use cases, known limitations and the extent to which those limits are disclosed in current documentation.
Another baseline AI diligence question is whether the target has the right to collect, use, disclose and process the data that it inputs into or uses to train its systems, acknowledging that AI regulations could limit use of AI in certain industry sectors, and for certain purposes, especially those using sensitive or marginally sensitive data sets. This may mean requirements on tracing the provenance of owned, licensed, scraped or observed data, and asking whether the relevant licenses actually permit AI training, commercial use and onward deployment. PE buyers should also distinguish between input risk and output risk, because the same target may have exposure on both sides: it may lack rights in its training data and also lack clear ownership or protection for AI-generated outputs it relies on commercially. Where the target uses third-party AI systems, diligence should additionally test compliance with vendor terms, (including the pricing terms and token usage), restrictions on use and known limitations such as discrimination, hallucinations or other errors.
Hidden exposure in AI vendor contracts and AI integration becoming an underwriting issue
AI-specific representations and warranties in purchase agreements are becoming more common, and buyers are increasingly using them to address liability that has been previously (and imperfectly) covered by standalone representations, including privacy and data use, IP ownership and licensing, model functionality and training, governance and compliance with laws. Even with AI-specific representations in the purchase agreements, real exposure, however, often sits one layer below the acquisition agreement in the AI clauses in the target’s own customer and vendor contracts. If the target provides AI tools to customers, its terms should include appropriate disclaimers on accuracy, reliability, non-infringement, support or suitability for sensitive fields and the failure to have adequate disclaimers can materially affect post-closing liability. Likewise, indemnification obligations, liability caps and dispute provisions in AI-related commercial contracts can leave a buyer holding more risk than a standard contract diligence summary would suggest.
When the target is a user of AI rather than a provider of third-party AI, potential PE buyers must assess whether the target has accepted vendor terms that disclaim key AI warranties while still embedding those tools into core business processes or customer-facing services. That mismatch can produce a familiar post-closing problem: the buyer inherits operational dependence on AI, but the contractual protection chain below the surface is thin. As US authorities have signaled they will police harmful or deceptive AI deployments, buyers should also diligence regulatory inquiries, consumer complaints and any internal escalation history tied to AI outputs or AI marketing.
In order to protect against these vulnerabilities, if undetected in due diligence, PE buyers are leaning on more robust AI representations and warranties in the purchase agreement to protect from improper or non-compliant usage of third-party AI, and unknown underlying breaches of the AI use related provisions in vendor contract.
Open source and training data risk can impact valuation
Open-source and training-data risk has become one of the fastest ways for a software-style diligence issue to become an AI valuation issue. Where the target utilized open source code to built its products or services, PE buyers will want comfort that the target has policies and procedures governing use, incorporation and distribution of such open-source code and materials into the target’s code base, and that the license terms for such open source models do not compromise the target’s proprietary rights in its AI technology. This review matters especially if the target is in software businesses, where value often resides in the code base, product architecture and freedom to commercialize at scale.
Training-data diligence raises a parallel set of questions, because licensed training data may be restricted to non-commercial use or may not authorize training at all, while web scraping can trigger copyright, contract, computer access, privacy or other claims that remain unsettled in key jurisdictions. Licensors of training data often give little comfort on whether they themselves had sufficient rights to gather and license the material for training purposes in the first place, which means provenance risk can sit upstream from the target. PE buyers should therefore treat data provenance as a fundamental diligence question rather than a footnote to privacy diligence, particularly where the AI model itself is a core asset.
Governance is becoming part of value
PE buyers increasingly want to see documented AI governance policies, user training, monitoring, incident reporting, human-in-the-loop controls and data governance that addresses retention, data rights, segregation, bias and explainability. Those controls matter not only because they reduce operational error, but also because they help demonstrate that the target can explain and audit how AI systems are used in practice. That is especially important where the target uses AI in a customer-facing or legally regulated function, because diligence now must account for whether specific AI laws apply and whether the target has already taken steps to comply. Even where the legal framework is still developing, buyers are better served by testing actual governance discipline than by accepting a generic statement that the target is “monitoring evolving law.”
In software-centric businesses, this AI diligence review should also extend to trade secret protection and the privacy and cybersecurity controls surrounding algorithms, models and training data. It is important to diligence the target’s trade secret policies and practices, because those protections often do more to protect AI assets than patents, copyright or trademark do. The target’s current policies, in other words, increasingly tell buyers whether the target has a bona fide AI capability or merely an AI narrative.
Indemnities and RWI are adjusting, but not always in the buyer’s favor
We are seeing AI diligence considerations starting to reshape deal protection. In some cases, buyers have tested the waters of treating liability caps and survival periods for AI-specific representations, warranties and indemnities separately from other standard provisions in purchase agreements. Tailored representation and warranty insurance has become increasingly plausible in AI-heavy transactions. Nonetheless, buyers should not assume that RWI will absorb the risks arising from the hardest AI questions, because insurers are taking a closer look at data provenance, model performance and other AI-specific reps and may carve those issues out of coverage.
The practical consequence is that the more foundational the AI issue is to enterprise value, the more likely it is to be resolved through diligence, price, covenant structure or a specific indemnity rather than through generic back-end insurance. This is particularly true where the issue goes to the target’s right to use the training data, generated data, AI model or code that underpins the business, because those are the areas where a buyer cannot easily paper over uncertainty after closing.
Software, data brokers and regulated industries are emerging as the clearest sector-specific pressure points
Sector-specific underwriting concerns are becoming sharper rather than broader. In software businesses, the first question is often whether the target truly owns the AI model or core stack it is selling, because companies dependent upon external AI providers may control the interface and customer relationship without controlling the underlying technology on which the business depends. Software buyers also need a careful read of open-source use, inbound and outbound IP licenses, customer AI terms and the liability framework around accuracy, non-infringement, support and sensitive-use restrictions.
In regulated industries (such as the health services, data broker and even the legal industry), diligence must go further into AI governance. For example, the insurance industry specifically, diligence must go deeper on algorithmic underwriting governance, because state regulators are scrutinizing underwriting models and buyers are expected to evaluate how the target’s AI use fits within the applicable regulatory framework. That means testing for transparency and fairness expectations, regulatory correspondence, consumer complaints and the degree to which human oversight remains embedded in underwriting or claims-related decisions. It also means involving sector-specific counsel early, because in regulated sectors the AI issue is no longer separable from the core regulatory license to operate.
Conclusion
The overarching point is that AI diligence is no longer about deciding whether the target is an “AI company.” It is about determining where AI sits inside the business model of every target company, whether the target has the rights and governance to use it lawfully and defensibly, and how the risks for any weakness should be allocated in the purchase agreement. PE buyers that ask those questions early through the diligence process are more likely to identify real underwriting issues before signing, rather than discovering after closing that the target’s AI story was stronger in pitch materials than in contracts, data rights or controls.